The interaction between KLRB1 (encoding CD161) and its ligand CLEC2D modulates the activity of NK cells and T cells, potentially suppressing their cytotoxic functions under certain conditions, thereby facilitating tumor immune evasion [45]. Here, KLRB1 is linked to neoplasm.